ELDN
Price
$2.23
Change
-$0.07 (-3.04%)
Updated
Oct 23, 11:07 AM (EDT)
Capitalization
186.9M
21 days until earnings call
Intraday BUY SELL Signals
ENTA
Price
$11.14
Change
-$0.48 (-4.13%)
Updated
Oct 23, 11:56 AM (EDT)
Capitalization
338.44M
24 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ELDN vs ENTA

ELDN vs ENTA Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ELDN vs. ENTA commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELDN is a StrongBuy and ENTA is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for ELDN with price predictions
Oct 22, 2026

ELDN sees its Stochastic Oscillator climbs out of oversold territory

On October 22, 2026, the Stochastic Oscillator for ELDN moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 66 instances where the indicator left the oversold zone. In 59 of the 66 cases the stock moved higher in the following days. This puts the odds of a move higher at over 89%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ELDN's RSI Oscillator exited the oversold zone, 25 of 28 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 89%.

The Moving Average Convergence Divergence (MACD) for ELDN just turned positive on October 21, 2026. Looking at past instances where ELDN's MACD turned positive, the stock continued to rise in 40 of 46 cases over the following month. The odds of a continued upward trend are 87%.

Following a +2.00% 3-day Advance, the price is estimated to grow further. Considering data from situations where ELDN advanced for three days, in 222 of 253 cases, the price rose further within the following month. The odds of a continued upward trend are 88%.

ELDN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ELDN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.

The Aroon Indicator for ELDN entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 71 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.661) is normal, around the industry mean (2.973). P/E Ratio (-2.556) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (438.009).

The Tickeron Price Growth Rating for this company is 83 (best 1 - 100 worst), indicating slightly worse than average price growth. ELDN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ELDN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for ENTA with price predictions
Oct 22, 2026

ENTA in +5.13% Uptrend, rising for three consecutive days on October 20, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where ENTA advanced for three days, in 211 of 272 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 41 of 60 cases where ENTA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 68%.

ENTA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ENTA as a result. In 65 of 79 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 82%.

The Moving Average Convergence Divergence Histogram (MACD) for ENTA turned negative on October 13, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 54 similar instances when the indicator turned negative. In 45 of the 54 cases the stock turned lower in the days that followed. This puts the odds of success at 83%.

ENTA moved below its 50-day moving average on October 01, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ENTA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.

The Aroon Indicator for ENTA entered a downward trend on October 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 27 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 44 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.349) is normal, around the industry mean (2.973). P/E Ratio (-4.802) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.550) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (5.285) is also within normal values, averaging (438.009).

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 61 (best 1 - 100 worst), indicating steady price growth. ENTA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ENTA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

FUNDAMENTALS RATINGS
ELDN vs ENTA: Fundamental Ratings
ELDN
ENTA
OUTLOOK RATING
1..100
1136
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
44
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
8361
P/E GROWTH RATING
1..100
9827
SEASONALITY SCORE
1..100
2750

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ENTA's Valuation (44) in the Biotechnology industry is in the same range as ELDN (71) in the Pharmaceuticals Major industry. This means that ENTA’s stock grew similarly to ELDN’s over the last 12 months.

ENTA's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ELDN (100) in the Pharmaceuticals Major industry. This means that ENTA’s stock grew similarly to ELDN’s over the last 12 months.

ENTA's SMR Rating (98) in the Biotechnology industry is in the same range as ELDN (100) in the Pharmaceuticals Major industry. This means that ENTA’s stock grew similarly to ELDN’s over the last 12 months.

ENTA's Price Growth Rating (61) in the Biotechnology industry is in the same range as ELDN (83) in the Pharmaceuticals Major industry. This means that ENTA’s stock grew similarly to ELDN’s over the last 12 months.

ENTA's P/E Growth Rating (27) in the Biotechnology industry is significantly better than the same rating for ELDN (98) in the Pharmaceuticals Major industry. This means that ENTA’s stock grew significantly faster than ELDN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ELDNENTA
RSI
ODDS (%)
Bullish Trend 1 day ago
89%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
68%
Momentum
ODDS (%)
N/A
Bearish Trend 1 day ago
82%
MACD
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
83%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 4 days ago
78%
Declines
ODDS (%)
Bearish Trend 10 days ago
88%
Bearish Trend 10 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
55%
Aroon
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
88%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (ELDN: $2.30 vs. ENTA: $11.62)
Brand notoriety: ELDN and ENTA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ELDN: 66% vs. ENTA: 69%
Market capitalization -- ELDN: $186.9M vs. ENTA: $338.44M
ELDN [@Biotechnology] is valued at $186.9M. ENTA’s [@Biotechnology] market capitalization is $338.44M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $135.64B. The average market capitalization across the [@Biotechnology] industry is $2.14B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ELDN’s FA Score shows that 0 FA rating(s) are green while ENTA’s FA Score has 1 green FA rating(s).

  • ELDN’s FA Score: 0 green, 5 red.
  • ENTA’s FA Score: 1 green, 4 red.
According to our system of comparison, ENTA is a better buy in the long-term than ELDN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ELDN’s TA Score shows that 5 TA indicator(s) are bullish while ENTA’s TA Score has 3 bullish TA indicator(s).

  • ELDN’s TA Score: 5 bullish, 2 bearish.
  • ENTA’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ELDN is a better buy in the short-term than ENTA.

Price Growth

ELDN (@Biotechnology) experienced а +1.32% price change this week, while ENTA (@Biotechnology) price change was +1.31% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.31%. For the same industry, the average monthly price growth was -16.25%, and the average quarterly price growth was -16.62%.

Reported Earning Dates

ELDN is expected to report earnings on Nov 13, 2026.

ENTA is expected to report earnings on Nov 16, 2026.

Industries' Descriptions

@Biotechnology (+1.31% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
ELDN
Daily Signal:
Gain/Loss:
ENTA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

ELDN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELDN has been loosely correlated with EDIT. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if ELDN jumps, then EDIT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELDN
1D Price
Change %
ELDN100%
+1.77%
EDIT - ELDN
35%
Loosely correlated
-0.80%
STRO - ELDN
34%
Loosely correlated
-4.63%
NTLA - ELDN
34%
Loosely correlated
-4.21%
RLAY - ELDN
33%
Poorly correlated
-0.38%
DNLI - ELDN
32%
Poorly correlated
-0.11%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IYR98.371.30
+1.34%
iShares U.S. Real Estate ETF (IYR)
RHTX19.98N/A
N/A
RH Tactical Outlook ETF (RHTX)
PIM3.00-0.01
-0.33%
Picard Medical Inc
ACKY17.42-0.09
-0.51%
VistaShares Target 15 ACKtivist Distribution ETF (ACKY)
BBHL17.49-0.14
-0.80%
BBH Select Large Cap ETF (BBHL)